Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ping An Biomedical is the specialized research and development arm of the Ping An Insurance Group, focusing on the intersection of biotechnology and advanced data science. The company leverages Ping An's massive healthcare database and AI capabilities to accelerate drug discovery and develop precision medicine solutions. Its primary research areas include oncology, immunology, and metabolic disorders, utilizing both traditional therapeutic modalities and innovative digital health tools. By integrating clinical data with laboratory research, Ping An Biomedical aims to create a closed-loop ecosystem that spans from early-stage discovery to clinical application within the broader Ping An healthcare network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ping An Biomedical.